NCT02645864
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Esophageal Neoplasms
Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.
304 public trials
107 recruiting studies
Esophageal Neoplasms trial results
NCT04764240
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
Not specified
Completed
Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy
NCT02644408
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- The First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China
NCT03116152
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- The Fifth Medical Center of PLA Ceneral Hospital Beijing, Beijing Municipality, China
Completed
Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma
NCT04225364
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Jingpei Li Guangzhou, Guangdong, China
NCT01598077
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +22 more
- Locations
-
- University of Chicago Medical Center University of Chicago (16) Chicago, Illinois, United States
- Massachusetts General Hospital SC-5 Boston, Massachusetts, United States
- University of Texas/MD Anderson Cancer Center UT MD Houston, Texas, United States
- University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States
- Conditions
- Adenocarcinoma Of Esophagus, Barrett Esophagus, Carcinoma, +24 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT02606916
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea
NCT02047305
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China